While commenting numerous articles about COVID-19 on its highly popular Linkedin feed for months, the former Yale University Professor, David Katz, had not paid much attention to hydroxychloroquine-based treatments.
Following numerous questions asked to him by his following, he plunged into the topic, and provided this analysis in the form of a “reality check” on his youtube channel.
His conclusions are very similar as those of Professor Harvey Risch.
Available scientific information, even if imperfect, suggests early treatment with hydroxychloroquine, associated with an antibiotic such as azithromycin, possibly in combination with nutritional supplement zinc, is advisable for high risk patients.
Watch his broadcast: